Daniel J. Mason

Lensfield Road
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma.

Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma.

Journal: EMBO molecular medicine

Published: December 04, 2024

A novel combination treatment for fragile X syndrome predicted using computational methods.

A novel combination treatment for fragile X syndrome predicted using computational methods.

Journal: Brain communications

Published: June 12, 2023

Using Machine Learning to Predict Synergistic Antimalarial Compound Combinations With Novel Structures.

Using Machine Learning to Predict Synergistic Antimalarial Compound Combinations With Novel Structures.

Journal: Frontiers in pharmacology

Published: May 02, 2018

Repurposing available drugs for neurodevelopmental disorders: The fragile X experience.

Repurposing available drugs for neurodevelopmental disorders: The fragile X experience.

Journal: Neuropharmacology

Published: January 04, 2018

Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.

Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.

Journal: Journal of medicinal chemistry

Published: April 07, 2017

Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.

Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.

Journal: BMC cancer

Published: February 25, 2016

Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives.

Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives.

Journal: Drug discovery today

Published: March 24, 2015

Synthesis and characterization of novel oxazines and demonstration that they specifically target cyclooxygenase 2.

Synthesis and characterization of novel oxazines and demonstration that they specifically target cyclooxygenase 2.

Journal: Bioorganic & medicinal chemistry letters

Published: February 10, 2015

Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis.

Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis.

Journal: Molecular bioSystems

Published: September 26, 2014

Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma.

Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma.

Journal: Bioorganic & medicinal chemistry letters

Published: August 31, 2014

Synthesis and characterization of novel 2-amino-chromene-nitriles that target Bcl-2 in acute myeloid leukemia cell lines.

Synthesis and characterization of novel 2-amino-chromene-nitriles that target Bcl-2 in acute myeloid leukemia cell lines.

Journal: PloS one

Published: May 07, 2014

Novel benzoxazine-based aglycones block glucose uptake in vivo by inhibiting glycosidases.

Novel benzoxazine-based aglycones block glucose uptake in vivo by inhibiting glycosidases.

Journal: PloS one

Published: February 28, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026